Rubius Therapeutics, Inc. announced the appointment of Dannielle Appelhans as President, effective November 15, 2022. Current president, Pablo J. Cagnoni, M.D., was appointed Chair of the board of directors, effective November 2, 2022, and will continue as president until November 15, 2022.